Dr. Fariba Navid, MD
Claim this profileChildren's Hospital Los Angeles
Expert in Cancer
Expert in Relapse
29 reported clinical trials
40 drugs studied
About Fariba Navid, MD
Education:
- Earned an MD from Tulane Medical School, New Orleans, Louisiana.
- Completed a Clinical Fellowship in Pediatric Oncology at the National Cancer Institute, Bethesda, MD.
Experience:
- Serves as Assistant Director of the Clinical Trials Program and COG Phase I & Pilot Consortium at Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles (CHLA) since September 2016.
- Holds the position of Associate Professor of Clinical Pediatrics at the Keck School of Medicine, University of Southern California.
- Has extensive experience in research and pediatric early-phase drug development, including previous work at St. Jude Children's Research Hospital.
Area of expertise
1Cancer
Global LeaderStage IV
NTRK1 positive
NTRK positive
2Relapse
Global LeaderStage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Fariba Navid, MD is currently running
Rapid Infusion of Dinutuximab
for Neuroblastoma
This trial aims to test if a cancer-fighting antibody can be given more quickly to children with high-risk neuroblastoma. The goal is to see if faster treatment is safe and effective, which could make it easier and less costly by allowing it to be done outside the hospital.
Recruiting3 awards Phase 1
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
More about Fariba Navid, MD
Clinical Trial Related2 years of experience running clinical trials · Led 29 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Fariba Navid, MD has experience with
- Larotrectinib
- Palbociclib
- Erdafitinib
- Selpercatinib
- Tipifarnib
- Vemurafenib
Breakdown of trials Fariba Navid, MD has run
Cancer
Relapse
Osteosarcoma
Brain Tumor
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Fariba Navid, MD specialize in?
Is Fariba Navid, MD currently recruiting for clinical trials?
Are there any treatments that Fariba Navid, MD has studied deeply?
What is the best way to schedule an appointment with Fariba Navid, MD?
What is the office address of Fariba Navid, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.